SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-062759
Filing Date
2017-11-28
Accepted
2017-11-28 19:25:49
Documents
2
Period of Report
2017-11-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1561
2 EX-24 DOCUMENT attachment1.htm EX-24 4645
  Complete submission text file 0001209191-17-062759.txt   7576
Mailing Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109
Business Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Issuer) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 400 DEXTER AVENUE NORTH SUITE 1200 SEATTLE WA 98109
Business Address
LEE ANN L. (Reporting) CIK: 0001723629 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36781 | Film No.: 171226552